Choosing the medicine that’s right for you is something to decide with the advice of your healthcare practitioner. It’s not just how good the medicines are, since everyone responds differently to medicines and we all have different goals, lifestyles and medical history.
The first thing to think about is – what are your weight loss goals? Whichever medicine you choose, you’ll need to commit to dietary changes and exercise too. Your BMI is used as a measure of your clinical eligibility, as it indicates how effective an injectable weight management treatment will be for you.
Check with your doctor that your weight loss goals are achievable.
Mounjaro® (tirzepatide), Wegovy® and Ozempic (semaglutide) and Saxenda (liraglutide) are all injectable treatments that suppress appetite. Mounjaro® and Wegovy® are the most common and come as pre-filled, self-administered pens. Ozempic is only licensed in the UK for Type 2 diabetes management, but it is used off-label for weight management. The ingredient in Saxenda called liraglutide, is now available as a generic medicine called Nevolat.
When choosing your medication, do your research on how well they work. Both Mounjaro® and Wegovy® are highly effective for weight loss. People on Mounjaro have been shown to lose 20.2% of their body weight over 72 weeks, while those on Wegovy® lost 13.7%.(1)
A new higher dose of 7.2mg of Wegovy® has recently been discovered to achieve greater weight loss results than the standard dose, with nearly half of those taking it losing 20% or more of their body weight.(2) EU approval for the new Wegovy® higher dose is expected in early 2026. You won’t be able to buy it in the UK until after this and it will initially only be available privately before it becomes available on the NHS.
Nevolat is the generic equivalent of Saxenda and is usually cheaper than branded GLP-1 agonists like Wegovy®, and Mounjaro®, however Wegovy®, and Mounjaro® have been shown to perform better in clinical trials. A medicine that’s more effective can help you reach your target weight sooner, which reduces the cost of treatment over time. When used correctly along with a change in diet and increase in exercise, people can expect to lose around 5-10% of their starting body weight using Nevolat treatment.
In a clinical trial, two thirds of people taking liraglutide lost at least 5% of their body weight.(3)
References
You’re most likely to get side effects when you first begin treatment and increase doses, so stick with it and maintain a healthy lifestyle. Speak to our pharmacy team if you’re concerned about side effects.
We’d be very happy to support your weight loss journey here at SlimEase with our responsibly sourced treatments.
Start your personal health consultation today.
Please key in your:
The calculator asks for information on your ethnic background because people from an Asian, Black African, African-Caribbean or Middle Eastern ethnic background have a higher chance of developing health problems at a lower BMI.
Your BMI result will be displayed as a number within a category:
You can then discuss your BMI with a qualified SlimEase representative.
Thinking about getting started? Ask us anything using the form below and we’ll help you work out the next step.
GMC No. 123456
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Last reviewed: 10/06/2026
Slimease,
No. 5 The Heights,
Weybridge,
KT13 0NY
Company Number:
01234578
General Pharmaceutical Council Registration Number: 01234578
© 2026 SlimEase. All Rights Reserved. Site by Blow Media
© 2026 SlimEase. All Rights Reserved. Site by Blow Media
Pellentesque commodo lacus at sodales sodales. Quisque sagittis orci ut diam condimentum, vel euismod erat placerat. In iaculis arcu eros, eget tempus orci facilisis id. Praesent lorem.
